Related by context. All words. (Click for frequent words.) 70 HER2 expression 70 atypical hyperplasia 70 endometrial carcinoma 70 PSADT 69 endometrial thickness 69 SUVmax 69 intima media thickness 68 #F FDG PET 68 advanced adenomas 68 carotid IMT 68 endometrial cancers 68 prostate cancer CaP 68 metabolite concentrations 68 CIN2 + 68 colorectal adenoma 68 hormone therapy estrogen 67 multivariable analysis 67 endometrial hyperplasia 67 serum estradiol 67 urinary calcium 67 lobular breast cancer 67 thyroglobulin 67 thyroid hormone levels 67 histological subtype 67 multivariate Cox 67 multivariate analyzes 66 conjugated equine estrogen 66 BRCA2 mutation carriers 66 gonococcal infection 66 multivariable adjusted 66 CVD mortality 66 miRNA expression 66 SLNB 66 ductal breast cancer 66 serum homocysteine 66 advanced neoplasia 66 chlamydial infection 66 pCR 66 ductal cancer 66 mammographically 66 coronary calcification 66 hip BMD 66 postmenopausal hormone 66 cytologic 66 ductal carcinomas 66 Inhibin B 66 adiponectin concentrations 66 intact parathyroid hormone 66 histopathologic diagnosis 66 carotid stenosis 65 bivariate 65 multiple logistic regression 65 logistic regression analyzes 65 advanced adenoma 65 serum PSA 65 adenoma recurrence 65 periprocedural MI 65 Lp PLA 2 65 CIN3 65 TT genotype 65 hydroxyvitamin D levels 65 F FDG PET 65 PSA nadir 65 Endometrial 65 specific antigen PSA 65 preoperative PSA 65 HER2 overexpression 65 atypical ductal hyperplasia 65 leiomyomas 65 BRCA mutation carriers 65 differential gene expression 65 PSA velocity 65 node metastases 65 tumor histology 65 telomere lengths 65 estrogen progestin therapy 65 epithelial ovarian cancer 65 mean ± SEM 65 androgen suppression 65 folate intake 65 HRCT 65 Subgroup analyzes 65 colorectal adenomas 65 CHD mortality 65 logistic regression model 65 inflammatory biomarkers 65 hyperhomocysteinemia 65 locoregional recurrence 65 EBRT 64 mRNA expression 64 invasive carcinoma 64 inhibin B 64 aminotransferases 64 triiodothyronine 64 multivariable Cox 64 abdominal adiposity 64 colorectal neoplasia 64 lumbar spine BMD 64 anogenital distance 64 Histopathologic 64 interobserver 64 logistic regression analysis 64 recurrent miscarriage 64 FDG-PET/CT 64 FDG uptake 64 carotid artery thickness 64 lymph node metastasis 64 sonographically 64 serum lipid levels 64 HGPIN 64 etiologic 64 central corneal thickness 64 homocysteine concentrations 64 baseline LDH 64 allele frequencies 64 meta regression 64 seminomas 64 genomewide 64 invasive lobular 64 SHBG levels 64 GSTP1 64 Histologic 64 FGFR2 gene 64 pT2 64 postoperative mortality 64 breast carcinoma 64 conditional logistic regression 64 ASCUS 64 colorectal neoplasms 64 elevated CRP 64 Genetic variants 64 serum vitamin D 64 FDG PET imaging 64 clinico pathological 64 serum phosphate 64 thyroid carcinoma 64 carotid plaque 64 axillary lymph nodes 64 confidence intervals CIs 64 PSA kinetics 64 plasma homocysteine 64 multivariate logistic regression 64 MetS 64 carotid plaques 64 magnesium intake 64 albumin excretion rate 64 logistic regression models 64 β blockers 63 hormone receptor negative 63 thyrotropin levels 63 antigen PSA levels 63 osteosarcomas 63 Cytogenetic 63 cerebral microbleeds 63 thromboembolism 63 lobular cancer 63 contralateral breast cancer 63 univariate 63 arterial calcification 63 selenium supplementation 63 bioavailable testosterone 63 antioxidant supplementation 63 subclinical atherosclerosis 63 Poisson regression 63 odds ratios ORs 63 bone scintigraphy 63 B7 H3 63 univariate analyzes 63 Heritability 63 breast endometrial 63 lupus anticoagulant 63 echocardiographic parameters 63 lobular involution 63 plasma lipid 63 serum BDNF 63 tibolone 63 APOE genotype 63 troponin T 63 nonmelanoma skin cancers 63 Adenomas 63 renal cell carcinomas 63 urolithiasis 63 gadolinium enhanced 63 prognostic variables 63 PCa 63 transrectal ultrasound guided 63 gastric cardia 63 atypia 63 intraobserver 63 MDRD 63 CIN2 63 AST ALT 63 biochemical recurrence 63 serum prostate 63 adnexal mass 63 clinicopathological 63 CC genotype 63 proton MR spectroscopy 63 impair fertility 63 adiponectin levels 63 liver metastasis 63 Subgroup analysis 63 recurrent venous thromboembolism 63 Cardiotoxicity 63 corrected QT interval 63 EUS FNA 63 albumin excretion 63 gallstone disease 63 HIV HCV coinfected 63 Electrophysiological 63 oophorectomy 63 lobular carcinoma 63 immunohistochemical 63 ovarian hormones 63 covariate 63 Multivariate analysis 63 Multivariate logistic regression 63 serum concentrations 63 nodal metastasis 63 IUGR 63 Reynolds Risk Score 63 antibody titer 63 serum urate levels 63 lymph node involvement 63 aortic stiffness 63 serum IGF 63 histopathologic examination 63 SLN biopsy 63 thiopurine 63 hormone receptor status 63 Bonferroni correction 63 oocytes retrieved 63 Kaplan Meier analysis 62 serum calcium levels 62 coinfection 62 postmenopausal breast cancer 62 preterm deliveries 62 Insulin sensitivity 62 ultrasonographic 62 spontaneous preterm birth 62 NMIBC 62 intestinal permeability 62 cisplatin resistant 62 antenatal depression 62 maternal serum 62 lactate dehydrogenase LDH 62 corneal thickness 62 STRIDE PD 62 subtrochanteric 62 rs# [001] 62 histologic subtype 62 hamartomas 62 precursor lesions 62 metabolic parameters 62 genotypic 62 psychiatric comorbidity 62 adjuvant radiation 62 urothelial carcinoma 62 serum calcium 62 thyroid stimulating hormone 62 neurocognitive function 62 cTnT 62 #F FDG 62 colonic polyps 62 Univariate analysis 62 plasma folate 62 IL#B 62 LV dysfunction 62 triacylglycerol concentrations 62 fasting insulin 62 subclinical hyperthyroidism 62 Multiple logistic regression 62 pre eclamptic 62 transabdominal 62 morphometric vertebral fractures 62 transvaginal sonography 62 serum PTH 62 ABL1 62 transient elastography 62 FDG PET scans 62 mammographic 62 CYP#D# genotype 62 MMSE score 62 neoplasias 62 Logistic regression 62 hematopoietic cancers 62 paricalcitol 62 glaucomatous 62 adenomatous polyps 62 pelvic lymphadenectomy 62 RNFL thickness 62 symptomatic VTE 62 gastric carcinoma 62 fetal chromosomal 62 gene amplification 62 Cystatin C 62 chromosomal instability 62 fetal malformations 62 spirometric 62 neutrophil counts 62 contralateral breast 62 nomograms 62 postoperative complication 62 Kruskal Wallis test 62 Randomized trials 62 Heavy menstrual bleeding 62 linkage disequilibrium 62 postoperative chemotherapy 62 MR spectroscopy 62 serum cortisol 62 ductal lobular 62 nonvertebral fractures 62 invasive carcinomas 62 LHRH agonists 62 pT3 62 lymphadenectomy 62 postmenopausal hormones 62 prostate carcinogenesis 62 vitamin D inadequacy 62 transgene expression 62 serum lipid 62 Digital Mammographic Imaging 62 seropositivity 62 testicular germ cell 62 airway responsiveness 62 mineral density 62 tHcy 62 invasive ductal 62 aneuploidy 62 Histopathological 62 aromatase inhibitor therapy 62 Genetic variation 62 KIF6 carriers 62 operable breast cancer 62 vascular dysfunction 62 nonfasting triglyceride levels 62 femoral neck BMD 62 invasive lobular carcinoma 62 immunoreactivity 62 microvessel density 62 variance ANOVA 62 thyrotropin 62 tumor subtypes 62 NNRTI resistance 62 serum creatinine levels 62 sentinel lymph node biopsy 62 recurrent VTE 62 lactate dehydrogenase 62 HER2 positive cancers 62 serum retinol 62 gastric adenocarcinoma 62 malignant nodules 62 BRCA carriers 62 protein excretion 61 APOC3 61 cTnI 61 platelet reactivity 61 chest radiographs 61 anovulatory infertility 61 RT PCR assay 61 relapsed MM 61 postoperative AF 61 thrombophilia 61 nucleotide substitutions 61 scintigraphic 61 arterial thickening 61 GnRH agonists 61 beta carotene supplementation 61 univariate analysis 61 abnormal Pap test 61 overt hypothyroidism 61 depressive symptomatology 61 thromboembolic disease 61 MGUS 61 chromosomal aberrations 61 D dimer 61 stratifying patients 61 HIV RNA 61 histopathologic 61 VADT 61 PHPT 61 Preoperative 61 preoperative chemotherapy 61 distant metastasis 61 nodal metastases 61 oestradiol 61 PCA3 scores 61 esophageal carcinoma 61 oesophageal adenocarcinoma 61 Estrogen Receptor 61 prostate carcinoma 61 QTc prolongation 61 interobserver reliability 61 Recurrence Score 61 androgen ablation 61 oncologic outcomes 61 adjuvant radiotherapy 61 microdeletions 61 Leitzmann 61 Immunohistochemistry 61 fluorescence intensity 61 QTc 61 hsCRP 61 Prognostic Value 61 familial aggregation 61 estimated glomerular filtration 61 sFlt 1 61 phytoestrogen intake 61 neoadjuvant chemotherapy 61 myocardial viability 61 micrometastasis 61 osteopenic 61 #.#ng/ml 61 dose Iluvien 61 progesterone receptor negative 61 atherothrombotic disease 61 sCJD 61 perioperative complications 61 Lp PLA2 61 ABCB1 61 serum selenium 61 eosinophil count 61 multivariate regression analysis 61 chemosensitivity 61 hippocampal atrophy 61 electron beam computed tomography 61 TOP2A 61 postintervention 61 tracer uptake 61 HIV seroconversion 61 virologic responses 61 BEXXAR Therapeutic Regimen 61 cranial irradiation 61 pulmonary metastases 61 serum leptin 61 angiographically 61 noncancer 61 glomerular filtration rate 61 polyp detection 61 polycystic ovary syndrome PCOS 61 DNA methylation patterns 61 definite stent thrombosis 61 basal cell carcinoma BCC 61 Hematologic 61 anogenital 61 meta analytic 61 PET CT scans 61 serum triglycerides 61 histologically proven 61 TOP2A gene 61 androgen deprivation 61 genetic polymorphisms 61 LRP5 61 troponins 61 CLA supplementation 61 clinically localized prostate 61 urine cytology 61 Comorbidities 61 prognostic significance 61 myo inositol 61 adrenomedullin 61 adjuvant therapies 61 heterozygotes 61 extracapsular extension 61 abnormal mammograms 61 adenoma 61 triglyceride concentrations 61 thyroid nodules 61 Univariate 61 Immunohistochemical staining 61 prospective longitudinal 61 perinatal outcomes 61 atheroma volume 61 nonpregnant women 61 ovulatory cycles 61 immunostaining 61 lobular carcinomas 61 aminotransferase 61 Logistic regression analysis 61 multiple linear regression 61 Breast Density 61 ovarian pancreatic 61 estrogen metabolites 61 thigh circumference 61 sonographic diagnosis 61 mtDNA mutations 61 preeclamptic 61 elevated depressive symptoms 61 thromboembolic 61 foveal thickness 61 axillary dissection 61 Screening Trial DMIST 61 Prostate Specific Antigen 61 spontaneous preterm delivery 61 hamartoma 61 MSMB 61 psychiatric morbidity 61 neurologic complications 61 prognostic indicators 61 Nonalcoholic Fatty Liver Disease 61 BRCA2 carriers 61 RBP4 61 BMD measurements 61 #β estradiol 61 SCr 61 glycosylated hemoglobin HbA1c 61 inhibin 61 UVB induced 60 breast cancer metastasis 60 neoadjuvant treatment 60 Biopsies 60 nonmelanoma skin cancer 60 penetrance 60 polyp recurrence 60 pharmacodynamic parameters 60 Hyperlipidemia 60 umbilical artery 60 testosterone secretion 60 retrospective cohort 60 axillary node 60 estimated GFR 60 radiosensitivity 60 ERalpha 60 microvascular disease 60 genotypic resistance 60 comorbidity 60 neoadjuvant therapy 60 micrometastases 60 Leydig cell 60 locoregional 60 antigen PSA 60 plasma cortisol 60 vertebral fracture 60 cTnT levels 60 transferrin saturation 60 thickness IMT 60 Sentinel Lymph Node Biopsy 60 leukocyte count 60 lignan intake 60 autonomic dysfunction 60 serum ferritin 60 endometrial biopsy 60 Proteinuria 60 urine NGAL 60 ovarian carcinoma 60 cystatin C 60 nulliparous women 60 FDG PET 60 Clusterin 60 subgroup analyzes 60 precancerous cervical 60 bilateral oophorectomy 60 extracolonic findings 60 androgen suppression therapy 60 glomerular filtration 60 nonvertebral fracture 60 breast cancer recurrences 60 singleton pregnancies 60 cortisol concentrations 60 nonmetastatic 60 Echocardiographic 60 arterial stiffening 60 gene APOE 60 immunohistochemical analysis 60 residual confounding 60 cardiac troponin T 60 ovarian malignancy 60 intima media thickness IMT 60 extramedullary 60 fasting plasma 60 pretest probability 60 DMIST 60 visceral adiposity 60 selenium intake 60 Progestin 60 distant metastases 60 colorectal carcinoma 60 microscopic hematuria 60 resected pancreatic cancer 60 salpingo oophorectomy 60 iPTH 60 Ki# 60 cardiac perfusion 60 LDL HDL 60 lobular 60 elevated LDH 60 Meta analyzes 60 bivariate analysis 60 biochemical relapse 60 perimenopausal women 60 microglial 60 Fracture Risk 60 mammographic breast density 60 confounding variables 60 missense mutations 60 rs# [004] 60 clinically insignificant 60 venous thromboembolic disease 60 alanine aminotransferase ALT 60 convergent validity 60 Breast Cancers 60 Depressive symptoms 60 renal cysts 60 microsatellite instability 60 amyloid deposition 60 cervical lesions 60 axial length 60 folic acid intake 60 transaminase levels 60 mucinous 60 nmol liter 60 multivariable analyzes 60 computed tomography scans 60 neurodevelopmental outcome 60 prospective multicenter study 60 immunohistochemical staining 60 pancreatic prostate 60 core needle biopsies 60 plasma pharmacokinetics 60 anti Mullerian hormone 60 urate levels 60 echogenicity 60 bivariate analyzes 60 PLCO 60 lung metastasis 60 cardiac troponin 60 ER CHOP 60 HNSCC 60 ascertainment bias 60 Adiposity 60 endometriosis ovarian cysts 60 HPV-#/# 60 deCODE BreastCancer TM 60 soluble CD# ligand 60 polygenic 60 serum folate concentrations 60 pancreatic adenocarcinoma 60 RQ PCR 60 Thromboembolism 60 T2 lesions 60 estrogen receptor negative 60 metachronous 60 Coronary artery calcium 60 prostate biopsy 60 DXA 60 bronchoalveolar lavage BAL 60 hypovitaminosis D 60 carotid atherosclerosis 60 underwent coronary angiography 60 varicoceles 60 QTc interval 60 QTc intervals 60 colorectal tumor 60 NP CRNs 60 prostate abnormalities 60 UVB exposure 60 bone density measurements 60 neurocognitive deficits 60 postmenopausal hormone therapy 60 HOXB# 60 lymphocytosis 60 neurosensory 60 Hilakivi Clarke 60 radioimmunoassay 60 strontium ranelate 60 follicle stimulating hormone FSH 60 extrapyramidal symptoms 60 pathologic examination 60 hematological parameters 60 Ejection Fraction 60 helical CT 60 leukocyte counts 60 Cholesterol Levels SPARCL 60 liver transplant recipients 60 fluorodeoxyglucose positron emission tomography 60 postoperative pulmonary 60 methylation patterns 60 BRCA1 mutations 60 #q# deletion 60 TIMP 1 60 abnormal cytology 60 infantile hemangioma 60 PTPN# 60 HER2 amplification 60 germline mutations 60 dopamine receptor gene 60 pairwise comparisons 60 colorectal cancer incidence 60 VLBW 60 aneuploid cells 60 semiquantitative 60 Drospirenone 60 LDL cholesterol concentrations 60 graft occlusion 60 monoclonal gammopathy 60 creatinine levels 60 serum parathyroid hormone 60 prolonged QT interval 60 chromosomal mutations 60 promoter methylation 60 Mammographic 60 methylation markers 60 UACR 60 irregular menstrual periods 60 clinicopathologic 60 carotid artery intima media 60 dysplastic nevi 60 CD# expression [001] 60 tumor recurrence 60 Sociodemographic 60 antiandrogens 60 parous women 60 plasma homocysteine levels 60 histologic subtypes 59 antiangiogenic agents 59 WOMAC pain 59 Bone Mineral Density 59 plasma triglycerides 59 sociodemographic factors 59 perioperative morbidity 59 microRNA expression 59 p# mutations 59 venous thrombosis 59 C Reactive Protein 59 densitometry 59 CHEK2 59 Anthracycline 59 electrophysiologic 59 Skin sterol 59 sarcosine 59 duplex ultrasonography 59 T1c 59 Schunkert 59 bronchoalveolar lavage 59 generalized estimating 59 PIGF 59 body fatness 59 grade squamous intraepithelial 59 Microalbuminuria 59 Am J Cardiol 59 orofacial clefts 59 CP CPPS 59 situ LCIS 59 RBP4 levels 59 linear regression analyzes 59 susceptibility loci 59 dysglycemia 59 Prolactin 59 NHANES III 59 esophageal squamous cell carcinoma 59 Genetic predisposition 59 T1a 59 sociodemographic characteristics 59 Breast Cancer Risk 59 gene polymorphisms 59 leiomyoma 59 Histological 59 genetic variants associated 59 metaanalysis 59 prospectively stratified 59 thrombotic complications 59 liver histology 59 rFSH 59 Prognostic 59 karyotype 59 somatic mutations 59 p# biomarker 59 chorioamnionitis 59 creatinine ratio 59 urine dipstick 59 dietary calcium intake 59 transfusion syndrome 59 URTI 59 Clinical Relevance 59 natriuretic peptides 59 atherosclerotic progression 59 qRT PCR 59 serum albumin 59 clinicopathological features 59 Invasive Breast Cancer 59 gene rearrangements 59 Prostate Cancer Risk 59 neurodevelopmental outcomes 59 liver biopsies 59 retinal nerve 59 uterine tumors 59 nonfasting triglycerides 59 Cardiorespiratory fitness 59 HbA 1c levels 59 spontaneous regression 59 T2DM 59 multivariate adjustment 59 SAXS 59 breast asymmetry 59 pretreatment serum 59 cervical carcinoma 59 de novo mutations 59 NGAL 59 lymph node metastases 59 morphologic 59 DEXA scans 59 obese postmenopausal 59 micronuclei 59 virologic response 59 catheter angiography 59 DHEA supplementation 59 SNP rs# [001] 59 F FDG uptake 59 estrogen receptor ER 59 acetabular dysplasia 59 treat NNT 59 prednisone prednisolone 59 artery calcification 59 Doppler echocardiography 59 unmeasured confounding 59 coronary artery calcification 59 axillary nodes 59 ADPKD 59 MGd 59 pyridostigmine 59 colonoscopic 59 adenoma detection 59 cytological 59 conventional angiography 59 serum testosterone 59 grade cervical intraepithelial 59 logistic regression 59 IDH1 mutation 59 chronic prostatitis 59 flutamide 59 epigenetic changes 59 μg liter 59 perioperative mortality 59 skeletal metastases 59 colorectal polyp 59 coronary stenosis 59 serum testosterone levels 59 Ultrasonography 59 N acetylaspartate 59 shorter telomere length 59 myeloperoxidase 59 postoperative radiotherapy 59 cerebral infarction 59 plus medroxyprogesterone acetate 59 adrenalectomy 59 Epidemiologic studies 59 prepregnancy BMI 59 papillary renal cell carcinoma 59 dietary folate intake 59 perineural invasion 59 Supplementary Table 59 vascular reactivity 59 folate deficiency 59 clusterin 59 neurodevelopmental impairment 59 serum uric acid 59 DEXA scan 59 fasting glucose levels 59 confidence interval #.#-#.# 59 conjugated estrogen 59 familial AF 59 Estrogens 59 nuchal translucency 59 Tumor Response 59 chi squared 59 tumor subtype 59 Metastatic Prostate Cancer 59 sonographic findings 59 cytogenetic abnormalities 59 lymphovascular invasion 59 urinary calcium excretion 59 VATS lobectomy 59 premenopausal 59 Comorbidity 59 #Gy 59 neuritic 59 prepubertal 59 testicular tumors 59 Catheter Associated 59 rs# [002] 59 Metastases 59 premenopausal breast cancer 59 malignant lesions 59 prognostic indicator 59 prion infection 59 Soy isoflavones 59 computerized tomography scans 59 POAG 59 antiangiogenic therapy 59 plasma selenium 59 KRAS mutations 59 salivary cortisol 59 hyperinsulinemic euglycemic clamp 59 cardioembolic stroke 59 N telopeptide 59 primary ovarian insufficiency 59 fibroids endometriosis 59 thermogram 59 tertiles 59 serum biomarkers 59 hyperintense lesions 59 Sjögren syndrome 59 antibody titres 59 serum LDL cholesterol 59 hippocampal volume 59 Erythropoietic therapies may 59 lumbar spine bone 59 peritoneal cancer 59 Hypertrophy 59 recurrent DVT 59 metaplasia 59 BRCA1 BRCA2 59 urodynamic 59 thyroid dysfunction 59 Postmenopausal Women 59 VEGF expression 59 postmenopausal estrogen 59 Placental 59 cortical atrophy 59 abdominal circumference 59 stone formers 59 basal cell nevus syndrome 59 cardiac computed tomography 59 ECG abnormalities 59 BMI z 59 adjuvant therapy 59 HOMA IR 59 highest tertile 59 Mutational 59 myocardial necrosis 59 BRCA1 mutation carriers 59 retrospectively analyzed 59 ErbB2 positive 59 virological response 59 familial clustering 59 postmenopausal hormone replacement 59 LVNC 59 mIU ml 59 potentially modifiable 59 A1c levels 59 radiotherapy RT 59 isoprostane 59 Sonographic 59 neuroimaging studies 59 biopsied tissue 59 chemoprevention trials 59 Meta Analysis 59 Cotinine 59 papillary thyroid carcinoma 59 preterm delivery 59 immunochemical 59 rheumatoid factor 59 neurocognitive impairment 59 Pearson correlation coefficients 59 Kaplan Meier estimates 59 atherothrombotic 59 carotid intima media 59 mesotheliomas 59 cervical adenocarcinoma 59 recurrent ovarian 59 familial pancreatic cancer 59 sitosterol 59 Chlamydia trachomatis infection 59 lipid abnormalities 59 hip circumference 59 p# activation 59 prostate cancer PCa 59 anal cancers 59 colorectal cancer CRC 59 breast lesions 59 estrogen estradiol 59 Prognostic factors 59 abnormal Pap smears 59 Prostate Specific Antigen PSA 59 ertapenem 59 serum lipids 59 noncardiac 59 rCBF 59 diabetes mellitus DM 59 intravesical therapy 59 Postoperative complications 59 normal karyotype 59 diffusivity 59 BCIRG 59 myocardial uptake 59 tic severity 59 Papillary 59 μmol L 59 prospectively defined 59 lymphocyte count 59 Mantel Haenszel 59 Hepatotoxicity 59 subfertility 59 Prostate specific antigen 59 hemorrhagic complications 59 Lung Cancer Risk 59 contrast induced nephropathy 59 PIB PET 59 postoperative hemorrhage